Bacterial Infection, IL-17 and Some Biomarkers with Related to Covid-19 Patients’ Outcome
SUMMARY. Since it has been a global pandemic for the past three years, the coronavirus disease 2019, or COVID19, has spread to all parts of the world. It first appears as pneumonia, which can progress to severe respiratory failure and has asits major hallmark a systemic inflammatory immune response brought on by an increased production of cytokinesthat causes a cytokine storm. Bacterial co-infections raise the risk of morbidity and mortality in COVID19 patients. The current study was conducted to investigate the impact of bacterial co-infection, IL-17, D-dimer, ferritin and CRP in Covid-19 pneumonia outcome. Four mL of blood samples were collected from 120 patients attending to AL-Amal hospital and Al-Sader medical city, Najaf/Iraq, from July 2021 - January 2022; 1.5 mL of blood kept in tube containing 3.2% sodium citrate to estimation D-dimer by Mini-vides and 2.5 mL in plane tube to separate serum that used to detect IL-17, ferritin and CRP. Patient divided into Critical 33 (27.5%), sever 42 (35%) and Mild/Moderate (M/M) 45 (37.5%), In addition to 60 apparently healthy subjects as controls group. The result indicated that a significant increase (p < 0.05) in mean serum level ofIL-17 in patients compare to healthy group, and the mean critical and server cases higher than M/M cases (101.79, 74.83, and 27.65) pg/mL. The results founded that most bacterial co-infection within critical and sever cases with 22(44%) and 26 (52%) respectively while M/M cases were 2(4%) only. Finally the results founded an elevated number of leukocyte, higher neutrophil and higher infection-related biomarkers (S. ferritin, D-dimer, and CRP) especially in critical cases (18.5± 2.62, 88.42±12.6, 738.68±154.41, 5.76±2.75, and 122.85±35.39) respectively.In conclusion the level ofIL-17, ferritin and D-dimer highly increased in Covid patients that correlated with severity of Covid pneumonia so by this biomarkers can recognized between two types of patients. Secondary bacterial infection increased progressive state of patients.